SONN

Sonnet BioTherapeutics Stock Price

0.6192
0.017 (2.82%)
Upgrade to Real-Time
Regular Market
0.6192

Low
0.5508

52 Week Range

High
3.415

Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
Small Cap Basic
Monthly Subscription
for only
$33.03
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
Company Name Stock Ticker Symbol Market Type
Sonnet BioTherapeutics Inc SONN NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.017 2.82% 0.6192 13:26:22
Open Price Low Price High Price Close Price Prev Close
0.6001 0.6001 0.6192 0.6022
Bid Price Ask Price Spread News
0.6175 0.6183 0.0008 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
2,975 1,417,267 $ 0.6066089 $ 859,727 - 0.5508 - 3.415
Last Trade Time Type Quantity Stock Price Currency
13:26:22 10,148 $ 0.6192 USD

Period:

Draw Mode:

Sonnet BioTherapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 36.01M 58.15M 56.95M $ - $ - -6.96 -0.10
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 47.00k 1.60%

more financials information »

Sonnet BioTherapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical SONN Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.590.61990.58350.59823592,961,4410.02924.95%
1 Month0.5740.800.55080.644507913,665,0270.04527.87%
3 Months1.512.070.55080.859564110,281,413-0.8908-58.99%
6 Months2.282.730.55080.98045525,355,391-1.66-72.84%
1 Year2.503.4150.55081.223,113,046-1.88-75.23%
3 Years6.2216.200.55082.133,006,244-5.60-90.05%
5 Years6.2216.200.55082.133,006,244-5.60-90.05%

Sonnet BioTherapeutics Description

Sonnet BioTherapeutics Holdings Inc is a clinical-stage biopharmaceutical company. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.


Your Recent History
NASDAQ
SONN
Sonnet Bio..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.